Today: 8 June 2026
Browse Category

NYSE:CVS 28 January 2026 - 9 May 2026

Humana Stock Jumps 11% as Medicare Advantage Hopes Put HUM Shares Back in Play

Humana Stock Jumps 11% as Medicare Advantage Hopes Put HUM Shares Back in Play

Humana shares surged 11.27% to $274.96 on Friday, following CVS’s raised 2026 profit outlook tied to improved medical-cost control. Humana’s own 2026 forecast remains under pressure from lower Medicare Star Ratings and limited funding. First-quarter revenue rose to $39.65 billion, but adjusted earnings fell to $10.31 per share. The company maintained its full-year adjusted earnings forecast at at least $9 a share.
9 May 2026
····
UnitedHealth Stock Is Climbing Again: The Medical-Cost Bet Driving UNH Shares

UnitedHealth Stock Is Climbing Again: The Medical-Cost Bet Driving UNH Shares

UnitedHealth shares rose 2.8% to $379.98 on Friday, marking a third straight gain as investors responded to signs of easing medical-cost pressure. The company reported Q1 revenue of $111.7 billion and raised its full-year adjusted earnings outlook to over $18.25 a share. UnitedHealthcare also announced it will cut prior authorization requirements for 30% of services by the end of 2026. Humana and CVS shares also climbed sharply.
9 May 2026
···
UNH Stock Moves Higher as UnitedHealth Cuts Prior Approval Rules and CVS Adds Cost Signal

UNH Stock Moves Higher as UnitedHealth Cuts Prior Approval Rules and CVS Adds Cost Signal

UnitedHealthcare will cut prior authorization requirements for 30% of remaining services by the end of 2026, including some outpatient surgeries and diagnostic tests. UnitedHealth Group shares rose about 1% to $367.55 Wednesday after the announcement. The company said prior authorization now applies to just 2% of its services. Investors are watching whether insurers can reduce paperwork without losing control of costs.
6 May 2026
··
Cigna’s Obamacare Exit Puts 369,000 Members on the Clock for 2027 Coverage

Cigna’s Obamacare Exit Puts 369,000 Members on the Clock for 2027 Coverage

Cigna Group will exit the Affordable Care Act individual insurance market after 2026, affecting about 369,000 members in 11 states who must find new coverage for 2027. The announcement came as Cigna reported first-quarter revenue of $68.5 billion and raised its 2026 earnings outlook. CVS Health’s Aetna previously withdrew from the ACA market for 2026, impacting about 1 million enrollees.
30 April 2026
··
UnitedHealth Stock Jumps as Centene Results Put Insurer Turnaround Back in Play

UnitedHealth Stock Jumps as Centene Results Put Insurer Turnaround Back in Play

UnitedHealth Group shares rose about 4% Tuesday after Centene raised its profit forecast, fueling optimism that medical-cost pressures may be easing for large insurers. UnitedHealth last week lifted its 2026 profit outlook and reported a first-quarter medical care ratio of 83.9%. Centene’s medical loss ratio came in below analyst estimates. UnitedHealth’s Optum unit continues to face cost and contract challenges.
28 April 2026
·····
US Stock Market Today: S&P 500, Dow, Nasdaq Slip as Oil Jumps and Fed Uncertainty Caps Rally

US Stock Market Today: S&P 500, Dow, Nasdaq Slip as Oil Jumps and Fed Uncertainty Caps Rally

The S&P 500 fell 0.32% to 7,086.48 Tuesday afternoon as rising oil prices and Treasury yields erased early gains. Brent crude climbed again after a 5.6% jump Monday, following U.S.-Iran ceasefire tensions. UnitedHealth raised its full-year outlook, and Amazon pledged up to $25 billion in Anthropic. March retail sales rose 1.7%, the biggest increase in a year.
21 April 2026
··········
Salesforce launches Agentforce Health AI agents to cut healthcare paperwork, adding HealthEx, Verily and Viz.ai

Salesforce launches Agentforce Health AI agents to cut healthcare paperwork, adding HealthEx, Verily and Viz.ai

Salesforce launched six new Agentforce Health AI agents for healthcare providers, payers, and public health, with integrations from HealthEx, Verily, and Viz.ai. The release coincides with AWS and Google Cloud debuting similar agentic AI healthcare platforms. Salesforce shares rose 3.8% in morning trading. Some functions are available now, with more planned for June and later in 2026.
5 March 2026
····
Amazon’s AWS rolls out Amazon Connect Health — AI agents target clinic calls, notes and codes

Amazon’s AWS rolls out Amazon Connect Health — AI agents target clinic calls, notes and codes

Amazon Web Services launched Amazon Connect Health, an AI platform that automates patient verification, scheduling, clinical notes, and medical coding by connecting directly to electronic health records. The tool is designed to transfer complex cases to staff. Amazon shares rose about 1% in early U.S. trading Thursday. UC San Diego Health reported saving about a minute per call using the system.
5 March 2026
····
ServiceNow stock slips after AI ‘Autonomous Workforce’ launch; what NOW investors watch next week

ServiceNow stock slips after AI ‘Autonomous Workforce’ launch; what NOW investors watch next week

ServiceNow shares fell 1.18% to $108.01 Friday, following a 5% surge the previous day, as the S&P 500 slipped 0.43%. The company announced new AI products, including EmployeeWorks and an autonomous service desk assistant, aiming to automate enterprise workflows. Analysts noted the shift from summarizing to action-taking AI but warned of slow adoption and budgeting challenges. Markets will watch for updates on pricing and uptake next week.
28 February 2026
··
UnitedHealth stock price slips after hours as investors brace for early-April Medicare rate call

UnitedHealth stock price slips after hours as investors brace for early-April Medicare rate call

UnitedHealth shares slipped 0.3% to $275.70 in after-hours trading Monday, while the S&P 500 and Nasdaq closed higher. Healthcare stocks lagged as investors eyed Medicare Advantage reimbursement and cost trends ahead of key policy updates. Humana dropped 2.3%, CVS Health fell 3.3%, and Cigna rose 0.8%. UnitedHealth last month warned of its first revenue decline in decades if proposed Medicare rates hold.
10 February 2026
····
UnitedHealth stock heads into Monday after UNH’s 3% jump — what investors watch next

UnitedHealth stock heads into Monday after UNH’s 3% jump — what investors watch next

UnitedHealth shares rose 3% Friday to $276.65 after a volatile week for managed-care stocks. Investors await insurer earnings from CVS Health on Feb. 10 and Humana on Feb. 11 for updates on Medicare Advantage trends. The Centers for Medicare and Medicaid Services has proposed a 0.09% payment increase for 2027 plans. The comment period on the 2027 rate notice closes Feb. 25.
8 February 2026
···
UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

UnitedHealth shares fell nearly 3% to $275.92 in after-hours trading Wednesday after the FTC announced a 10-year insulin pricing settlement with Cigna’s Express Scripts, increasing scrutiny on OptumRx and CVS Caremark. Investors are watching for an FTC oral argument Feb. 5 and a House hearing on drug prices Feb. 11. CVS and Cigna shares also declined. UnitedHealth did not comment.
5 February 2026
·····
UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth shares rose 1% to $289.75 Monday, outperforming peers as Humana, Elevance, and Cigna declined. Truist and JPMorgan cut price targets but kept positive ratings. Investors focused on Medicare Advantage payment rates and 2026 cost trends after last week’s sector sell-off. Final 2027 Medicare Advantage rates are expected in April.
2 February 2026
·······
UnitedHealth stock slips after-hours as PBM fee disclosure rule adds fresh pressure on UNH

UnitedHealth stock slips after-hours as PBM fee disclosure rule adds fresh pressure on UNH

UnitedHealth shares fell 0.6% to $292.29 in after-hours trading Thursday after the U.S. Labor Department proposed new disclosure rules for pharmacy benefit managers. The proposal would require PBMs to reveal fee and compensation details. Investors are also closely watching upcoming Medicare Advantage rate decisions. Related health insurer stocks showed mixed movement late Thursday.
30 January 2026
·····
Elevance Health stock rises as ELV steadies after cautious 2026 outlook and Medicare rate jitters

Elevance Health stock rises as ELV steadies after cautious 2026 outlook and Medicare rate jitters

Elevance Health shares rose 1% to $345.44 Thursday, leading gains in managed-care stocks after policy and earnings volatility. The company forecast 2026 adjusted EPS of at least $25.50, below analyst expectations, and warned of revenue declines amid Medicaid and ACA headwinds. Medicare Advantage payments are set for a minimal 0.09% increase in 2027, rattling the sector. ACA enrollment for 2026 dropped to about 23 million as subsidies ended.
29 January 2026
·····
Dow Jones flattens near 49,000 as S&P 500 hits 7,000; Fed and Big Tech earnings loom

Dow Jones flattens near 49,000 as S&P 500 hits 7,000; Fed and Big Tech earnings loom

The Dow rose 49.62 points to 49,053.03 by midday Wednesday as the S&P 500 briefly topped 7,000 before retreating. Intel jumped 11.3%, while UnitedHealth plunged nearly 20% after the Trump administration proposed a 0.09% Medicare Advantage rate hike for 2027. The Fed is expected to hold rates steady. Seagate surged 19.3% on earnings.
28 January 2026
·······
1 2 3

Stock Market Today

  • Zepto Files Updated DRHP for $1 Billion IPO Amid Intensified Quick Commerce Competition
    June 8, 2026, 4:34 PM EDT. Zepto, the quick commerce startup, filed an updated draft red herring prospectus (DRHP) with India's Securities and Exchange Board for a $1 billion IPO. The offer consists of Rs 8,010 crore fresh shares and an offer-for-sale from existing investors like Nexus Venture Partners. Valued at $7 billion in October 2025, Zepto plans to expand its dark store network and invest in technology using IPO proceeds. The company reported Rs 7,498 crore revenue in Q4, a 75% rise year-on-year, with a narrowed net loss of Rs 1,539 crore. Zepto aims for a July listing amid fierce competition from Blinkit, Instamart, Amazon, and Flipkart in the fast-growing but highly contested 10-minute delivery segment.

Latest articles

Snap Shares Climb as Debt Markets Send Signal

Snap Drops Again as Wall Street Stays Wary

8 June 2026
Snap plunged 2.1% to $5.64, underperforming a tech rebound, as investors weighed improved cash flow and a recent S&P credit upgrade against ongoing ad-market pressure, cost cuts, and spending on Specs; the stock’s weakness stood out as peers like Pinterest gained, highlighting market doubts about Snap’s ability to sustain growth amid tough competition and uncertain ad budgets.
Dow Drops After Hours, AI Rally Sidesteps Blue Chips

Dow Drops After Hours, AI Rally Sidesteps Blue Chips

8 June 2026
The Dow Jones fell 104.70 points, or 0.21%, to 50,762.08 as tech and chip stocks rebounded sharply, with the Philadelphia SE Semiconductor Index up 6.2% after Friday’s $1 trillion selloff; Apple dropped 1.4% despite its AI event, and investors now await Wednesday’s inflation data and Middle East energy risks as the next key tests for the market’s fragile rebound.
Nasdaq rises as AI names find support after market selloff

Nasdaq rises as AI names find support after market selloff

8 June 2026
Nasdaq surged 1.27% as investors snapped up AI and chip stocks after Friday’s rout, with the Philadelphia Semiconductor Index jumping 6.2%; Citigroup hiked its S&P 500 year-end target to 8,100 on AI demand, but Goldman Sachs warned strong jobs data makes a Fed rate hike more plausible, posing risks to growth stocks if inflation surprises.
Tesla Stock Bounces Over $400 After China Sales Beat—But There’s a Caveat

Tesla Stock Bounces Over $400 After China Sales Beat—But There’s a Caveat

8 June 2026
Tesla shares soared over 5% to $411.66 after a China sales report showed May retail sales up 22.5%, ending a two-month decline, and J.P. Morgan upgraded the stock, citing rising value from autonomy and software; the rally outpaced the Nasdaq as investors bet on Tesla’s China resilience and technology story despite a lofty price-to-earnings ratio of about 378.
Go toTop